Special Issue "New Vaccine Technologies and Approaches 2.0"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (15 December 2021) | Viewed by 11200
Interests: vaccine bioprocessing; downstream process development; technology transfer to LMIC; vaccine manufacture; vaccine analytics; bioprocess quality control
Interests: anti-parasitic vaccines; antibody repertoire in vaccination; human mAbs expression
The urgent global need for vaccines to prevent COVID-19, allied with the rapid development of immunization approaches targeting SARS-CoV-2, evidences how the vaccinology field has substantially evolved lately. New technologies for antigen design, the rapid discovery of high neutralizing monoclonal antibodies and the development of new delivery platforms are only a few examples. In addition, in recent years, innumerous changes have occurred in terms of density, age and traveling habits of the world population. Thus, changes in vaccine development that can address all these issues need to be implemented.
This Special Issue aims to gather the latest research on new vaccine technologies and approaches, including, but not limited to, the following topics:
- Antigen design;
- Delivery platforms;
- Nanoparticle viral vectors;
- Vaccine development for outbreaks;
- Immunization with whole organisms;
- DNA vaccines;
- RNA vaccines;
- Genetic adjuvants.
We look forward to your contribution to this Special Issue!
Dr. Stephen A. Morris
Dr. Camila Coelho
Assistant Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Vaccine Technologies
- Novel approaches for vaccination